PG
TEVA icon

PEAK6 Group’s Teva Pharmaceuticals TEVA Stock Holding History

PEAK6 Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$1.41M Hold
57,900
– – 0.01% 1675
2018
Q1 		$990K Sell
57,900
-290,700
-83% -$5.68M ﹤0.01% 1980
2017
Q4 		$6.61M Buy
348,600
+175,000
+101% +$2.63M 0.03% 677
2017
Q3 		$3.06M Buy
173,600
+55,000
+46% +$1.24M 0.02% 1070
2017
Q2 		$3.94M Buy
118,600
+104,500
+741% +$3.23M 0.02% 866
2017
Q1 		$452K Sell
14,100
-105,400
-88% -$3.6M ﹤0.01% 2341
2016
Q4 		$4.33M Sell
119,500
-124,400
-51% -$4.97M 0.03% 792
2016
Q3 		$11.2M Buy
243,900
+24,300
+11% +$1.27M 0.08% 305
2016
Q2 		$11M Sell
219,600
-382,900
-64% -$20.4M 0.09% 289
2016
Q1 		$32.2M Sell
602,500
-105,500
-15% -$6.19M 0.26% 48
2015
Q4 		$46.5M Buy
708,000
+23,100
+3% +$1.43M 0.31% 30
2015
Q3 		$38.7M Buy
684,900
+415,800
+155% +$27M 0.2% 77
2015
Q2 		$15.9M Sell
269,100
-107,700
-29% -$6.64M 0.09% 253
2015
Q1 		$23.5M Buy
376,800
+316,500
+525% +$18.4M 0.18% 94
2014
Q4 		$3.47M Sell
60,300
-5,200
-8% -$290K 0.03% 883
2014
Q3 		$3.52M Buy
65,500
+32,300
+97% +$1.71M 0.03% 851
2014
Q2 		$1.74M Sell
33,200
-98,200
-75% -$5.02M 0.02% 1158
2014
Q1 		$6.94M Sell
131,400
-3,100
-2% -$143K 0.06% 438
2013
Q4 		$5.39M Sell
134,500
-422,300
-76% -$16.6M 0.04% 675
2013
Q3 		$10.5M Buy
556,800
+487,500
+703% +$19M 0.07% 309
2013
Q2 		$2.72K Buy
+69,300
New +$2.7M 0.01% 1253

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

PEAK6 Group's TEVA Position: Q2 2018 in Review

PEAK6 Group increased its Teva Pharmaceuticals (TEVA) stake by 681% in Q2 2018, buying an estimated $930K and bringing the position to 52,302 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #1757.

PEAK6 Group first reported a position in TEVA in Q2 2013 and has held it in 18 quarters since. The position peaked at $29.2M in Q1 2014. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • PEAK6 Group held 52,302 shares of Teva Pharmaceuticals worth $1.27M as of Q2 2018.
  • PEAK6 Group bought 45,607 Teva Pharmaceuticals shares in Q2 2018, an estimated $930K.
  • Teva Pharmaceuticals made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1757 holding.
  • PEAK6 Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
  • PEAK6 Group's Teva Pharmaceuticals position peaked at $29.2M in Q1 2014.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.